Clinical Trials in Detroit

Showing 12341-12360 of 16,931 trials

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

This phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme. Gossypol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more

National Cancer Institute (NCI)56 participantsStarted Jan 2008

Birmingham, Alabama, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +5 more locations

COMPLETEDPhase 3< 1 mile

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

NCT01000727

This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or urgent coronary revascularization (e.g. medical procedures performed to restore the normal blood flow in patients with atherosclerosis)) when treatment is started within 30 days after an acute coronary syndrome (also called ACS).

Acute Coronary Syndrome

GlaxoSmithKline13,026 participantsStarted Dec 2009

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +911 more locations

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Find Trials by Condition in Detroit

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Biomarkers of Mild and Moderate Traumatic Brain Injury

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

Multi-Center Comparative Trial of the ASR™-XL Acetabular Cup System vs. the Pinnacle™ Metal- on- Metal Total Hip System

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

PAXIL CR Bioequivalence Study

Safety Study to Evaluate FluMist in Immunocompromised Children

Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting

HeRO Vascular Access Device Bacteremia Study

Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)